Petrova and colleagues designed a genetically modified MSC for expressing collagen type VII alpha 1 chain (COL7A1) for the treatment of recessive dystrophic epidermolysis bullosa (RDEB) [92]. This evidence concerns the gene COL7A1 and recessive dystrophic epidermolysis bullosa.